Free Trial
→ Your book attached (From Profits Run) (Ad)tc pixel Free DMRA Stock Alerts

Damora Therapeutics, Inc. Common Stock (DMRA) Institutional Ownership

Damora Therapeutics, Inc. Common Stock logo
$24.16 -0.83 (-3.32%)
As of 05/8/2026 04:00 PM Eastern
Compare

Institutional Ownership Changes (13F Filings) for Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA)

Current
Institutional Ownership
Percentage
14.20%
Number of
Institutional Buyers
(last 12 months)
10
Total
Institutional Inflows
(last 12 months)
$15.19M
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$49.60K
Get DMRA Insider Trade Alerts

Want to know when executives and insiders are buying or selling Damora Therapeutics, Inc. Common Stock stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

DMRA Institutional Buying and Selling by Quarter

Damora Therapeutics, Inc. Common Stock Major Shareholders & Ownership History

Export
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/18/2026Ikarian Capital LLC285,710$6.57M0.5%N/A17.857%
2/18/2026Janus Henderson Group PLC1,739$40K0.0%N/A0.109%
2/18/2026Boothbay Fund Management LLC95,798$2.20M0.0%N/A5.987%
2/17/2026Jain Global LLC120,566$2.77M0.0%N/A7.535%
2/12/2026Remedium Capital Partners LLC120,473$2.77M1.6%N/A7.544%
2/9/2026Geode Capital Management LLC11,573$266K0.0%N/A0.725%
1/30/2026 Sigma Planning Corp14,500$334K0.0%N/A0.906%
11/17/2025Connective Capital Management LLC26,956$100K0.1%N/A2.027%
11/17/2025Novo Holdings A S86,579$322K0.0%-13.3%6.510%
11/14/2025Virtu Financial LLC13,128$49K0.0%N/A0.987%
11/14/2025Two Sigma Investments LP20,296$76K0.0%N/A1.526%
2/17/2025Squarepoint Ops LLC12,701$59K0.0%N/A0.962%
2/13/2025Renaissance Technologies LLC15,044$70K0.0%-29.6%1.140%
10/24/2024Novo Holdings A S99,913$1.21M0.1%-96.0%0.369%
11/15/2023Laurion Capital Management LP88,580$64K0.0%-53.5%0.327%
8/8/2023Belvedere Trading LLC15,037$38K0.0%N/A0.055%
8/4/2023Simplex Trading LLC11,399$28K0.0%+3,699.7%0.042%
8/2/2023MAI Capital Management245,281$618K0.0%-4.0%0.956%
7/10/2023Trust Co. of Toledo NA OH22,432$57K0.0%+86.9%0.087%
5/10/2023MAI Capital Management255,453$508K0.0%+9.5%0.995%
2/9/2023MAI Capital Management233,283$268K0.0%-31.2%0.912%
9/16/2022Federated Hermes Inc.40,000$69K0.0%+53.8%0.158%
7/19/2022MAI Capital Management320,860$555K0.0%N/A1.270%
7/15/2022Marquette Asset Management LLC60,244$104K0.0%+31.6%0.238%
4/26/2022Marquette Asset Management LLC45,765$101K0.0%+25.4%0.181%


DMRA Institutional Ownership - Frequently Asked Questions

During the previous two years, 13 institutional investors and hedge funds held shares of Damora Therapeutics, Inc. Common Stock. The most heavily invested institutionals were Ikarian Capital LLC ($6.57M), Jain Global LLC ($2.77M), Remedium Capital Partners LLC ($2.77M), Boothbay Fund Management LLC ($2.20M), Sigma Planning Corp ($334K), Novo Holdings A S ($322K), and Geode Capital Management LLC ($266K).Learn more on Damora Therapeutics, Inc. Common Stock's institutional investors.

14.20% of Damora Therapeutics, Inc. Common Stock's stock is owned by institutional investors. Learn more on DMRA's institutional investor holdings.

Of the 11 institutional investors that purchased Damora Therapeutics, Inc. Common Stock's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Ikarian Capital LLC ($285.71K), Jain Global LLC ($120.57K), Remedium Capital Partners LLC ($120.47K), Boothbay Fund Management LLC ($95.80K), Connective Capital Management LLC ($26.96K), Two Sigma Investments LP ($20.30K), and Sigma Planning Corp ($14.50K).

Institutional investors have bought a total of 710,739 shares in the last 24 months. This purchase volume represents approximately $15.19M in transactions.

The following institutional investors have sold Damora Therapeutics, Inc. Common Stock stock in the last 24 months: Novo Holdings A S ($13.33K).

Institutional investors have sold a total of 13,334 shares in the last 24 months. This volume of shares sold represents approximately $49.60K in transactions.


Related Companies

This page (NASDAQ:DMRA) was last updated on 5/10/2026 by MarketBeat.com Staff.
From Our Partners
Before you buy SpaceX shares, consider this alternative approach
SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceedin...
Weiss Ratings | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
Massive Data Leak Exposes 512,000-Line Code That Could Change Society Forever
"You won't believe what I discovered at 4 World Trade Center" When our financial media correspondent travel...
Chaikin Analytics | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Collect $1,170 a month from silver
I've Rarely Seen This With Silver This combination - 20% dividends + 68% share appreciation - never happens...
Investors Alley | Sponsoredtc pixel
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel